| All In One Home Healthcare Llc | |
| 290 Merrimack Street Suite 108, Lawrence, Massachusetts 1843 | |
| (978) 258-0917 | |
| Name | All In One Home Healthcare Llc |
|---|---|
| Location | 290 Merrimack Street Suite 108, Lawrence, Massachusetts |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 227681 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 1810, 1824, 1844, 1845, 1863, 1876, 1886 |
| NPI Number | 1467829796 |
| Organization Name | ALL IN ONE HOME HEALTHCARE LLC |
| Address | 6 Cushing Pl, Chelmsford, MA 01824 |
| Phone Number | 978-258-0917 |
News Archive
A recent large German study has shown that a new combination therapy for breast cancer treatment leads to a lowered risk of the disease coming back. A commentary on this landmark clinical trial has been published in the latest issue of the Journal of Clinical Oncology by the researchers Masey Ross and Charles Geyer Jr. from the VCU Massey Cancer Center. The commentary was titled, "Nab-Paclitaxel: A New Standard of Care in Neoadjuvant Therapy of High-Risk Early Breast Cancer?"
Researchers at Moffitt Cancer Center in Tampa, Fla., and the University of South Florida (USF) College of Medicine evaluated the experience of medical students who participated in videotaped sessions where they practiced conveying difficult news to "standardized patients" (SPs). The SPs role-played patients with a variety of cancers and who were receiving bad medical news.
With emergency department visits spiking around the holidays, patients may be inclined to seek care at freestanding emergency departments in an urgent situation.
Scientists at Seattle Biomedical Research Institute and Northwestern University Feinberg School of Medicine have reached a major milestone in the effort to wipe out some of the most lethal diseases on the planet. As leaders of two large structural genomics centers, they've experimentally determined 500 three-dimensional protein structures from a number of bacterial and protozoan pathogens, which could potentially lead to new drugs, vaccines and diagnostics to combat deadly infectious diseases.
The first medical students enrolled in SELECT, an innovative program designed to educate the physician leaders of the future, will arrive on the USF Health campus this week.
› Verified 7 days ago
| Quality Rating: |
News Archive
A recent large German study has shown that a new combination therapy for breast cancer treatment leads to a lowered risk of the disease coming back. A commentary on this landmark clinical trial has been published in the latest issue of the Journal of Clinical Oncology by the researchers Masey Ross and Charles Geyer Jr. from the VCU Massey Cancer Center. The commentary was titled, "Nab-Paclitaxel: A New Standard of Care in Neoadjuvant Therapy of High-Risk Early Breast Cancer?"
Researchers at Moffitt Cancer Center in Tampa, Fla., and the University of South Florida (USF) College of Medicine evaluated the experience of medical students who participated in videotaped sessions where they practiced conveying difficult news to "standardized patients" (SPs). The SPs role-played patients with a variety of cancers and who were receiving bad medical news.
With emergency department visits spiking around the holidays, patients may be inclined to seek care at freestanding emergency departments in an urgent situation.
Scientists at Seattle Biomedical Research Institute and Northwestern University Feinberg School of Medicine have reached a major milestone in the effort to wipe out some of the most lethal diseases on the planet. As leaders of two large structural genomics centers, they've experimentally determined 500 three-dimensional protein structures from a number of bacterial and protozoan pathogens, which could potentially lead to new drugs, vaccines and diagnostics to combat deadly infectious diseases.
The first medical students enrolled in SELECT, an innovative program designed to educate the physician leaders of the future, will arrive on the USF Health campus this week.
› Verified 7 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 60 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 100 | 98.6 |
| How often the home health team checked patients’ risk of falling | 100 | 99.6 |
| How often the home health team checked patients for depression | 96.7 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | - | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 26.7 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | - | 96.4 |
News Archive
A recent large German study has shown that a new combination therapy for breast cancer treatment leads to a lowered risk of the disease coming back. A commentary on this landmark clinical trial has been published in the latest issue of the Journal of Clinical Oncology by the researchers Masey Ross and Charles Geyer Jr. from the VCU Massey Cancer Center. The commentary was titled, "Nab-Paclitaxel: A New Standard of Care in Neoadjuvant Therapy of High-Risk Early Breast Cancer?"
Researchers at Moffitt Cancer Center in Tampa, Fla., and the University of South Florida (USF) College of Medicine evaluated the experience of medical students who participated in videotaped sessions where they practiced conveying difficult news to "standardized patients" (SPs). The SPs role-played patients with a variety of cancers and who were receiving bad medical news.
With emergency department visits spiking around the holidays, patients may be inclined to seek care at freestanding emergency departments in an urgent situation.
Scientists at Seattle Biomedical Research Institute and Northwestern University Feinberg School of Medicine have reached a major milestone in the effort to wipe out some of the most lethal diseases on the planet. As leaders of two large structural genomics centers, they've experimentally determined 500 three-dimensional protein structures from a number of bacterial and protozoan pathogens, which could potentially lead to new drugs, vaccines and diagnostics to combat deadly infectious diseases.
The first medical students enrolled in SELECT, an innovative program designed to educate the physician leaders of the future, will arrive on the USF Health campus this week.
› Verified 7 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 68.2 | 79.6 |
| How often patients got better at getting in and out of bed | 72 | 81.1 |
| How often patients got better at bathing | 99.2 | 82.3 |
| How often patients’ breathing improved | - | 82.8 |
| How often patients’ wounds improved or healed after an operation | - | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 92.7 | 75 |
| How often home health patients had to be admitted to the hospital | - | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | - | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 96.7 | 94 |
News Archive
A recent large German study has shown that a new combination therapy for breast cancer treatment leads to a lowered risk of the disease coming back. A commentary on this landmark clinical trial has been published in the latest issue of the Journal of Clinical Oncology by the researchers Masey Ross and Charles Geyer Jr. from the VCU Massey Cancer Center. The commentary was titled, "Nab-Paclitaxel: A New Standard of Care in Neoadjuvant Therapy of High-Risk Early Breast Cancer?"
Researchers at Moffitt Cancer Center in Tampa, Fla., and the University of South Florida (USF) College of Medicine evaluated the experience of medical students who participated in videotaped sessions where they practiced conveying difficult news to "standardized patients" (SPs). The SPs role-played patients with a variety of cancers and who were receiving bad medical news.
With emergency department visits spiking around the holidays, patients may be inclined to seek care at freestanding emergency departments in an urgent situation.
Scientists at Seattle Biomedical Research Institute and Northwestern University Feinberg School of Medicine have reached a major milestone in the effort to wipe out some of the most lethal diseases on the planet. As leaders of two large structural genomics centers, they've experimentally determined 500 three-dimensional protein structures from a number of bacterial and protozoan pathogens, which could potentially lead to new drugs, vaccines and diagnostics to combat deadly infectious diseases.
The first medical students enrolled in SELECT, an innovative program designed to educate the physician leaders of the future, will arrive on the USF Health campus this week.
› Verified 7 days ago
News Archive
A recent large German study has shown that a new combination therapy for breast cancer treatment leads to a lowered risk of the disease coming back. A commentary on this landmark clinical trial has been published in the latest issue of the Journal of Clinical Oncology by the researchers Masey Ross and Charles Geyer Jr. from the VCU Massey Cancer Center. The commentary was titled, "Nab-Paclitaxel: A New Standard of Care in Neoadjuvant Therapy of High-Risk Early Breast Cancer?"
Researchers at Moffitt Cancer Center in Tampa, Fla., and the University of South Florida (USF) College of Medicine evaluated the experience of medical students who participated in videotaped sessions where they practiced conveying difficult news to "standardized patients" (SPs). The SPs role-played patients with a variety of cancers and who were receiving bad medical news.
With emergency department visits spiking around the holidays, patients may be inclined to seek care at freestanding emergency departments in an urgent situation.
Scientists at Seattle Biomedical Research Institute and Northwestern University Feinberg School of Medicine have reached a major milestone in the effort to wipe out some of the most lethal diseases on the planet. As leaders of two large structural genomics centers, they've experimentally determined 500 three-dimensional protein structures from a number of bacterial and protozoan pathogens, which could potentially lead to new drugs, vaccines and diagnostics to combat deadly infectious diseases.
The first medical students enrolled in SELECT, an innovative program designed to educate the physician leaders of the future, will arrive on the USF Health campus this week.
› Verified 7 days ago
Home Health Of Haverhill Location: 360 Merrimack Street Build 9, Lawrence, Massachusetts 1843 Ratings: Phone: (800) 933-5593 | |
Amedisys Home Health Care Location: 290 Merrimack Street, Suite 241, Lawrence, Massachusetts 1843 Ratings: Phone: (781) 547-6601 | |
Boston Home Health Aides, Llc Location: 1 Union Street, Lawrence, Massachusetts 1840 Ratings: Phone: (617) 264-0200 | |
Afya Home Care, Llc Location: 439 South Union Street, Suite B12, Lawrence, Massachusetts 1843 Ratings: Phone: (978) 258-7271 | |
Avenue Homecare Services, Inc Location: 280 Haverhill Street, Lawrence, Massachusetts 1840 Ratings: NA Phone: (978) 323-9729 | |
Middlesex Healthcare Services, Inc Location: 599 Canal Street, Suite 6e-9, Lawrence, Massachusetts 1840 Ratings: NA Phone: (978) 375-1516 |